Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Blanchet

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Ebiomedicine|November 4, 2025
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patientsBlaise Pasquiers, Benoit Blanchet, Xavier Puéchal, et al.
Frontiers in Immunology|August 8, 2022
Low-dose mycophenolate mofetil improves survival in a murine model of <i>Staphylococcus aureus</i> sepsis by increasing bacterial clearance and phagocyte functionFanny Alby-Laurent, Nadia Belaïdouni, Benoit Blanchet, et al.
Experimental Hematology|July 5, 2003
Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpressionEmiko Komura, Hédia Chagraoui, Véronique Mansat de Mas, et al.
Journal of Clinical Pharmacology|February 11, 2010
Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation periodAnne Sophie Benichou, Benoit Blanchet, Filomena Conti, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resectionCléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.
Targeted Oncology|May 21, 2017
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated MelanomaFanny Garlan, Benoit Blanchet, Nora Kramkimel, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2017
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patientsAlicja Puszkiel, Gaëlle Noé, Pascaline Boudou-Rouquette, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Investigational New Drugs|October 19, 2011
Saturable absorption of sorafenib in patients with solid tumors: a population modelMarilyne Hornecker, Benoit Blanchet, Bertrand Billemont, et al.
Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Ebiomedicine|November 4, 2025
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patientsBlaise Pasquiers, Benoit Blanchet, Xavier Puéchal, et al.
Frontiers in Immunology|August 8, 2022
Low-dose mycophenolate mofetil improves survival in a murine model of <i>Staphylococcus aureus</i> sepsis by increasing bacterial clearance and phagocyte functionFanny Alby-Laurent, Nadia Belaïdouni, Benoit Blanchet, et al.
Experimental Hematology|July 5, 2003
Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpressionEmiko Komura, Hédia Chagraoui, Véronique Mansat de Mas, et al.
Journal of Clinical Pharmacology|February 11, 2010
Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation periodAnne Sophie Benichou, Benoit Blanchet, Filomena Conti, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2023
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resectionCléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, et al.
Targeted Oncology|May 21, 2017
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated MelanomaFanny Garlan, Benoit Blanchet, Nora Kramkimel, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2017
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patientsAlicja Puszkiel, Gaëlle Noé, Pascaline Boudou-Rouquette, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Investigational New Drugs|October 19, 2011
Saturable absorption of sorafenib in patients with solid tumors: a population modelMarilyne Hornecker, Benoit Blanchet, Bertrand Billemont, et al.
Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
Pageof 11